{"id":{"repo_id":"usf","oai_identifier":"oai:digitalcommons.usf.edu:etd-11818"},"canonical_url":"https://search.ndltd.org/etd/usf/oai:digitalcommons.usf.edu:etd-11818","repository":{"repo_id":"usf","name":"University of South Florida","base_url":"https://digitalcommons.usf.edu/do/oai/"},"display":{"title":"SARS-CoV-2 Neurotropism: Understanding Effects at the Blood-Brain Barrier and Hematogenous Neuroinvasiveness","abstract":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus responsible for COVID-19, has provisional counts of over 110 million documented cases and 1.218 million deaths (as of February 2024) in the United States since January 2020. SARS-CoV-2 is an airborne respiratory virus that primarily infects the lungs via the ACE2 receptor but has well-documented secondary target organs including the kidneys, the gastrointestinal tract, the heart, and the skin. SARS-CoV-2 also infects the brain, but the hematogenous route of viral entry to brain is still not fully characterized. Understanding how SARS-CoV-2 traverses the blood-brain barrier (BBB) as well as how it affects the molecular functions of the BBB are unclear. In this study, we investigated the roles of the receptors angiotensin converting enzyme 2 (ACE2) and dipeptidyl peptidase 4 (DPP4) in SARS-CoV-2 infection of the discrete cellular components of a transwell BBB model comprising HUVECs, astrocytes, pericytes. Our results demonstrate that direct infection on the BBB model does not modulate paracellular permeability. Also, our results show that SARS-CoV-2 utilizes clathrin and caveolin-mediated endocytosis to traverse the BBB resulting in direct infection of the brain-side of the BBB model with minimal endothelial infection. In conclusion, the BBB is susceptible to SARS-CoV-2 infection in multiple ways including direct infection of endothelium, astrocytes, and pericytes involving ACE2 and/or DPP4 and the blood-to-brain transcytosis, which is a stochastic event that does not require the presence of host receptors.Up to 30% of individuals with mild to severe disease develop long COVID, exhibiting diverse neurologic symptoms including dementias. However, there is a paucity of knowledge of molecular brain markers and whether these can precipitate the onset of Alzheimer’s disease (AD). Herein, we report the brain gene expression profiles of severe COVID-19 patients showing increased expression of innate immune response genes and genes implicated in AD pathogenesis. The use of a mouse-adapted strain of SARS-CoV-2 (MA10) in an aged mouse model shows evidence of viral neurotropism, prolonged viral infection, increased expression of p-tau particularly in the brain parenchyma adjacent to CD31+ staining. Brain histopathology shows AD signatures including increased tau-phosphorylation, tau-oligomerization in aged MA10 infected mice. The results of gene expression profiling of SARS-CoV-2-infected and AD brains and studies in the MA10 aged mouse model taken together provide evidence suggesting that SARS-CoV-2 infection alters expression of genes in the brain associated with the development of AD.","abstract_html":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus responsible for COVID-19, has provisional counts of over 110 million documented cases and 1.218 million deaths (as of February 2024) in the United States since January 2020. SARS-CoV-2 is an airborne respiratory virus that primarily infects the lungs via the ACE2 receptor but has well-documented secondary target organs including the kidneys, the gastrointestinal tract, the heart, and the skin. SARS-CoV-2 also infects the brain, but the hematogenous route of viral entry to brain is still not fully characterized. Understanding how SARS-CoV-2 traverses the blood-brain barrier (BBB) as well as how it affects the molecular functions of the BBB are unclear. In this study, we investigated the roles of the receptors angiotensin converting enzyme 2 (ACE2) and dipeptidyl peptidase 4 (DPP4) in SARS-CoV-2 infection of the discrete cellular components of a transwell BBB model comprising HUVECs, astrocytes, pericytes. Our results demonstrate that direct infection on the BBB model does not modulate paracellular permeability. Also, our results show that SARS-CoV-2 utilizes clathrin and caveolin-mediated endocytosis to traverse the BBB resulting in direct infection of the brain-side of the BBB model with minimal endothelial infection. In conclusion, the BBB is susceptible to SARS-CoV-2 infection in multiple ways including direct infection of endothelium, astrocytes, and pericytes involving ACE2 and/or DPP4 and the blood-to-brain transcytosis, which is a stochastic event that does not require the presence of host receptors.Up to 30% of individuals with mild to severe disease develop long COVID, exhibiting diverse neurologic symptoms including dementias. However, there is a paucity of knowledge of molecular brain markers and whether these can precipitate the onset of Alzheimer’s disease (AD). Herein, we report the brain gene expression profiles of severe COVID-19 patients showing increased expression of innate immune response genes and genes implicated in AD pathogenesis. The use of a mouse-adapted strain of SARS-CoV-2 (MA10) in an aged mouse model shows evidence of viral neurotropism, prolonged viral infection, increased expression of p-tau particularly in the brain parenchyma adjacent to CD31+ staining. Brain histopathology shows AD signatures including increased tau-phosphorylation, tau-oligomerization in aged MA10 infected mice. The results of gene expression profiling of SARS-CoV-2-infected and AD brains and studies in the MA10 aged mouse model taken together provide evidence suggesting that SARS-CoV-2 infection alters expression of genes in the brain associated with the development of AD.","abstract_has_math":false,"creators":["Martinez, Taylor E."],"institution":"University of South Florida","degree_name":"Doctor of Philosophy (Ph.D.)","degree_level":"Dissertation","degree_discipline":"Medicine","degree_department":null,"school":null,"contributors":["Subhra Mohapatra, Ph.D.","Paula Bickford, Ph.D.","Alison Willing, Ph.D.","Jerome Breslin, Ph.D.","Andreas Seyfang, Ph.D."],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2024,"date_issued":"2024-06-13T07:00:00Z","date_published":"2024-06-13T07:00:00Z","updated_at":"2026-11-19T08:50:05Z","subjects":["ACE2","Alzheimer's Disease","BBB","SARS-CoV-2","Transcytosis","Medicine and Health Sciences","Neurosciences"],"languages":[],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":"https://digitalcommons.usf.edu/etd/10531","outbound_label":"Repository record","outbound_source":"dc:identifier","record_url":"https://digitalcommons.usf.edu/etd/10531","record_label":"Repository record","record_kind":"record","record_source":"dc:identifier","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://digitalcommons.usf.edu/do/oai/?verb=GetRecord&metadataPrefix=oai_etdms&identifier=oai%3Adigitalcommons.usf.edu%3Aetd-11818","prefix":"oai_etdms"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Subhra Mohapatra, Ph.D.","Paula Bickford, Ph.D.","Alison Willing, Ph.D.","Jerome Breslin, Ph.D.","Andreas Seyfang, Ph.D."]},{"key":"dc:creator","label":"Author","values":["Martinez, Taylor E."]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2024-06-13T07:00:00Z"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Medicine"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Dissertation","Ph.D."]},{"key":"thesis:degree_name","label":"Degree Name","values":["Doctor of Philosophy (Ph.D.)"]},{"key":"thesis:institution_name","label":"Thesis Institution Name","values":["University of South Florida"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["ACE2","Alzheimer's Disease","BBB","SARS-CoV-2","Transcytosis","Medicine and Health Sciences","Neurosciences"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://digitalcommons.usf.edu/etd/10531"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus responsible for COVID-19, has provisional counts of over 110 million documented cases and 1.218 million deaths (as of February 2024) in the United States since January 2020. SARS-CoV-2 is an airborne respiratory virus that primarily infects the lungs via the ACE2 receptor but has well-documented secondary target organs including the kidneys, the gastrointestinal tract, the heart, and the skin. SARS-CoV-2 also infects the brain, but the hematogenous route of viral entry to brain is still not fully characterized. Understanding how SARS-CoV-2 traverses the blood-brain barrier (BBB) as well as how it affects the molecular functions of the BBB are unclear. In this study, we investigated the roles of the receptors angiotensin converting enzyme 2 (ACE2) and dipeptidyl peptidase 4 (DPP4) in SARS-CoV-2 infection of the discrete cellular components of a transwell BBB model comprising HUVECs, astrocytes, pericytes. Our results demonstrate that direct infection on the BBB model does not modulate paracellular permeability. Also, our results show that SARS-CoV-2 utilizes clathrin and caveolin-mediated endocytosis to traverse the BBB resulting in direct infection of the brain-side of the BBB model with minimal endothelial infection. In conclusion, the BBB is susceptible to SARS-CoV-2 infection in multiple ways including direct infection of endothelium, astrocytes, and pericytes involving ACE2 and/or DPP4 and the blood-to-brain transcytosis, which is a stochastic event that does not require the presence of host receptors.Up to 30% of individuals with mild to severe disease develop long COVID, exhibiting diverse neurologic symptoms including dementias. However, there is a paucity of knowledge of molecular brain markers and whether these can precipitate the onset of Alzheimer’s disease (AD). Herein, we report the brain gene expression profiles of severe COVID-19 patients showing increased expression of innate immune response genes and genes implicated in AD pathogenesis. The use of a mouse-adapted strain of SARS-CoV-2 (MA10) in an aged mouse model shows evidence of viral neurotropism, prolonged viral infection, increased expression of p-tau particularly in the brain parenchyma adjacent to CD31+ staining. Brain histopathology shows AD signatures including increased tau-phosphorylation, tau-oligomerization in aged MA10 infected mice. The results of gene expression profiling of SARS-CoV-2-infected and AD brains and studies in the MA10 aged mouse model taken together provide evidence suggesting that SARS-CoV-2 infection alters expression of genes in the brain associated with the development of AD."]},{"key":"dc:title","label":"Title","values":["SARS-CoV-2 Neurotropism: Understanding Effects at the Blood-Brain Barrier and Hematogenous Neuroinvasiveness"]}]}],"canonical_facts":{"dc:contributor":["Subhra Mohapatra, Ph.D.","Paula Bickford, Ph.D.","Alison Willing, Ph.D.","Jerome Breslin, Ph.D.","Andreas Seyfang, Ph.D."],"dc:creator":["Martinez, Taylor E."],"dc:date":["2024-06-13T07:00:00Z"],"dc:description":["Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus responsible for COVID-19, has provisional counts of over 110 million documented cases and 1.218 million deaths (as of February 2024) in the United States since January 2020. SARS-CoV-2 is an airborne respiratory virus that primarily infects the lungs via the ACE2 receptor but has well-documented secondary target organs including the kidneys, the gastrointestinal tract, the heart, and the skin. SARS-CoV-2 also infects the brain, but the hematogenous route of viral entry to brain is still not fully characterized. Understanding how SARS-CoV-2 traverses the blood-brain barrier (BBB) as well as how it affects the molecular functions of the BBB are unclear. In this study, we investigated the roles of the receptors angiotensin converting enzyme 2 (ACE2) and dipeptidyl peptidase 4 (DPP4) in SARS-CoV-2 infection of the discrete cellular components of a transwell BBB model comprising HUVECs, astrocytes, pericytes. Our results demonstrate that direct infection on the BBB model does not modulate paracellular permeability. Also, our results show that SARS-CoV-2 utilizes clathrin and caveolin-mediated endocytosis to traverse the BBB resulting in direct infection of the brain-side of the BBB model with minimal endothelial infection. In conclusion, the BBB is susceptible to SARS-CoV-2 infection in multiple ways including direct infection of endothelium, astrocytes, and pericytes involving ACE2 and/or DPP4 and the blood-to-brain transcytosis, which is a stochastic event that does not require the presence of host receptors.Up to 30% of individuals with mild to severe disease develop long COVID, exhibiting diverse neurologic symptoms including dementias. However, there is a paucity of knowledge of molecular brain markers and whether these can precipitate the onset of Alzheimer’s disease (AD). Herein, we report the brain gene expression profiles of severe COVID-19 patients showing increased expression of innate immune response genes and genes implicated in AD pathogenesis. The use of a mouse-adapted strain of SARS-CoV-2 (MA10) in an aged mouse model shows evidence of viral neurotropism, prolonged viral infection, increased expression of p-tau particularly in the brain parenchyma adjacent to CD31+ staining. Brain histopathology shows AD signatures including increased tau-phosphorylation, tau-oligomerization in aged MA10 infected mice. The results of gene expression profiling of SARS-CoV-2-infected and AD brains and studies in the MA10 aged mouse model taken together provide evidence suggesting that SARS-CoV-2 infection alters expression of genes in the brain associated with the development of AD."],"dc:identifier":["https://digitalcommons.usf.edu/etd/10531"],"dc:subject":["ACE2","Alzheimer's Disease","BBB","SARS-CoV-2","Transcytosis","Medicine and Health Sciences","Neurosciences"],"dc:title":["SARS-CoV-2 Neurotropism: Understanding Effects at the Blood-Brain Barrier and Hematogenous Neuroinvasiveness"],"thesis:degree_discipline":["Medicine"],"thesis:degree_level":["Dissertation","Ph.D."],"thesis:degree_name":["Doctor of Philosophy (Ph.D.)"],"thesis:institution_name":["University of South Florida"]},"updated_at":"2026-11-19T08:50:05Z"}